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A B S T R A C T
The study deals with the connection between metabolic syndrome (MS) and smoking habits of 1602 males and 828 fe-
males aged 18–97 years from the island of Hvar, Croatia. The age-adjusted prevalence of MS was higher in males (18.1–
31.2%) than females (9.7–24.2%) by all five criteria that were defined, except the one by AHA/NHLBI. The overall preva-
lence of MS reached 12.9% by WHO using body mass index (BMI), 13.1% by EGIR, 14.5% by WHO using waist to hip ra-
tio (WHR), 18.2% by NCEP/ATP III, 18.9% by AHA/NHLBI, and 26.7% by IDF criteria. The prevalence of smoking hab-
its was similar in males (24.7%) and females (23.8%). The frequency of mild, moderate and heavy smoking was higher in
males than females, 35.8:26.6%, 31.0:27.0%, and 35.9:7.7%, respectively. Age and sex had significant influence on BMI
and WHR, both being highest in male former smokers (28.15 kg/m2 and 0.973, respectively) and in female non-smokers
(27.18 kg/m2 and 0.869, respectively). The appearance of arterial hypertension (HTN) differed according to frequency of
smoking; males had higher prevalence than females using WHO and EGIR criteria of blood pressure ³140/90 mmHg,
even after age adjustment. In males and females respectively, systolic HTN in non-smokers was 20.7:15.1%, in former
smokers 17.9:15.2% and in current smokers 16.9:13.0%; diastolic HTN in non-smokers was 19.8:12.7%, in former smokers
22.4:10.5%, and in current smokers 11.3:9.1%. By NCEP, AHA, IDF criteria of blood pressure ³130/85 mmHg, arterial
HTN was also more prevalent in males than females; systolic HTN in non-smokers being 31.4:19.8%, in former smokers
29.9:12.7%, and in current smokers 25.4:11.1%; and diastolic HTN in non-smokers was 20.5:11.5%, in former smokers
24.8:11.3%, and in current smokers 14.7:9.4%. According to AHA/NHLBI and IDF criteria of high plasma glucose as
³5.6 mmoL/L, both males and females in all the three categories of smokers had glucose levels above the normal range
(5.80–6.31mmol/L in males and 5.80–5.91 mmol/L in females), except female current smokers (5.51 mmol/L). By WHO,
EGIR and NCEP/ATP III criteria of high plasma glucose as ³6.1 mmmol/L, only male non-smokers (6.31 mmol/L) and
former smokers (6.24 mmol/L) had elevated levels. Considering normal HDL-cholesterol as >1.0 mmol/L in males and
>1.2 mmol/L in females, both males and females in all the three smoker’s categories had HDL within normal range; fe-
males having higher HDL levels (1.52 mmol/L) than males (1.30 mmol/L). Considering normal value for triglycerides as
<1.7 mmol/L, male former smokers (1.76 mmol/L) and current smokers (1.81 mmol/L) had higher levels; and as a whole
group triglycerides were higher in males than females, 1.66:1.37 mmol/L respectively. The prevalence of MS differed be-
tween males and females using various MS criteria. Both males and females had the highest prevalence of MS by IDF
criteria; male former smokers 60.5%, female non-smokers 51.4%, male non-smokers 53.8%, female former smokers
38.2%, and lowest in both male and female current smokers 39.8 and 33.0% respectively. In males, the lowest prevalence
of MS was observed in non-smokers by AHA criteria (30.5%), in former smokers by WHO criteria (35.7%), and in current
smokers using EGIR criteria (18.1%). Females in all the three smoker’s categories had the lowest prevalence of MS using
EGIR and WHO criteria. MS were less prevalent in current smokers than in non-smokers and former smokers.
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Introduction
Metabolic syndrome (MS) is a maior public health
problem and is associated with atherosclerotic cardiovas-
cular diseases (CVD) and Type 2 diabetes mellitus1–8.
Among various MS risk factors, which includes obesity,
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glucose intolerance, low HLD-cholesterol, high triglycer-
ides, presence of arterial hypertension (HTN), hyperuri-
cemia, and hyperfibrinogenemia, smoking habits could
be an important predisposing factor for development of
atherosclerosis and CVD as its complication because of
the presence of high levels of free-oxygen radicals in
blood and changes in lipoprotein metabolisms7–10. Smo-
king habit is an important public health problem and
known as an propitious factor in aging process because of
induction of inflammatory processes by free-oxygen radi-
cals causing oxidative damage and vascular endothelial
dysfunction leading to atherosclerosis and its associated
complications such as coronary heart disease, cerebro-
vascular and other vascular diseases, Type 2 diabetes, es-
sential tremor, cancer etc.
The article deals with the prevalence of smoking hab-
its of a population living in the Hvar island at the eastern
Adriatic Croatian coast, relating smoking habits to meta-
bolic diseases based on clinical and biochemical parame-
ters. Previous reports had shown high prevalence of obe-
sity and arterial HTN in these island comunities7,8. The
Croatian islands are inhabited by a unique group of pop-
ulations, predominantly of Slavic origins. These island-
ers are distinct from the mainland Europeans by practic-
ing an agricultural subsistence in a rural setting and for
the most part living on a typical Mediterranean way of
life. The aim of the study is to search the connection be-
tween metabolic syndrome and smoking habits in an is-
land population of the Adriatic.
Material and Methods
Study participants and measurements
The study was conducted in the Middle Dalmatian is-
land of Hvar on the eastern Adriatic coast of Croatia. Ac-
cording to the 2001 census, the total population of Hvar
was 11,103 in 24 settlements consisting of 21 villages and
3 small townships. A total of 1430 individuals partici-
pated: 602 males and 828 females, aged 18 to 97 years,
from various settlements to enter the study (Table 1). All
examinations were done in 2007 and 2008 with part of
the survey questionnaire directed to smoking habits. The
following anthropometric parameters were used for this
analysis: body mass index (BMI = weight in kg/height in
m2), waist circumference, hip circumference, and waist
to hip ratio (WHR = waist circumference/hip circumfer-
ence)10. Blood pressure measurements were recorded
three times and all the three measurements were used to
calculate the mean systolic (SPB) and diastolic blood
pressure (DBP). Blood samples were drawn after a 12-
-hours of fast and serum was separated and kept frozen
until shipped to the biochemical laboratory in Zagreb,
where biochemical tests were performed for fasting plas-
ma glucose (FPG), HbA1c (%), insulin, total cholesterol,
LDL and HDL cholesterol, triglycerides (TG), uric acid,
creatinine, fibrinogen, and calcium concentrations using
standard methods previously described11.
Definitions of smoking habits
and metabolic traits
The examinees were grouped into three categories of
smoking habits: non-smokers, former smokers and cur-
rent smokers. Smoking index was calculated according to
the number of cigarettes smoked per day multiplied by
years of smoking habits12. Current smokers were further
divided into three groups: mild smokers with a smoking
index between 1–200, moderate smokers with a smoking
index between 201–600 and heavy smokers with a smok-
ing index of 601 and more. Former smokers were the in-
dividuals who stopped smoking at least 30 days before
the examination. They were also further divided into
three sub-groups: former mild smokers, former moderate
smokers and former heavy smokers as defined above.
As regards to metabolic diseases, according to the
World Health Organization (WHO) definition of meta-
bolic syndrome13,14 an individual with MS should be hy-
perglycaemic with a fasting plasma glucose ³6.1 mmol/L
and presence of at least two of the following risk factors:
abdominal obesity with WHR>0.90 in men and >0.85 in
women and/or generalized obesity with BMI>30 kg/m2;
serum triglycerides ³1.69 mmol/L and/or HDL-choles-
terol <0.9 mmol/L in men and <1.00 mmol/L in women;
and high arterial blood pressure as ³140 mmHg systolic
and ³90 mmHg diastolic and/or therapy.
The definition of the European Group for the study of
the Insulin Resistance (EGIR)15,16 includes presence of
insulin resistance along with two of the following risk
factors: fasting plasma glucose ³6.1 mmol/L; waist cir-
cumference ³94 cm in males and ³80 cm in females; se-
rum triglycerides ³2.00 mmol/L and/or HDL-cholesterol
<1.00 mmol/L; and high blood pressure as ³140 mmHg
systolic and ³90 mmHg diastolic and/or therapy.
The definition of the Third Report of the National
Cholesterol Education Program (NCEP), Evaluation,
and Treatment of High Blood Cholesterol in Adults,
Adult Treatment Panel III (ATP III)17 does not explicitly
include insulin resistence as a requirment, rather defines
MS as co-occurence of three or more of the following five
risk factors: abdominal obesity with waist circumference
³102 cm in men and ³88 cm in women; hyperglycaemia
with fasting plasma glucose ³6.1 mmol/L and/or therapy
for Type 2 diabetes; serum triglycerides ³1.69 mmol/L
and/or therapy; HDL-cholesterol <1.04 mmol/L in men
and <1.29 mmol/L in women and/or therapy; and high
blood pressure as ³130 mmHg systolic and ³85 mmHg di-
astolic and/or therapy.
The American Heart Association and The National
Heart, Lung and Blood Institute18 (AHA/NHLBI) inclu-
des waist circumference ³102 cm in men and ³88 cm in
women and presence of at least two of the following risk
factors: fasting plasma glucose ³5.6 mmol/L; serum tri-
glycerides ³1.69 mmol/L; serum HDL-cholesterol <1.04
mmol/L in men and <1.29 mmol/L in women; and high
blood pressure as ³130 mmHg systolic and ³85 mmHg
distolic and/or therapy.
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The International Diabetes Federation definition
(IDF)19–21 includes central obesity as an important crite-
rion with waist circumference in Mediterranean’s to be
³94 cm in males and ³80 cm in females, and presence of
at least two of the following risk factors: fasting plasma
glucose ³5.6 mmol/L and/or therapy; serum triglycerides
³1.7 mmol/L and/or therapy; HDL-cholesterol level
<1.00 mmol/L in males and <1.30 mmol/L in females;
and high blood pressure as ³130 mmHg systolic and ³85
mmHg diastolic and/or therapy.
Statistical analysis
The means and standard errors were computed to de-
termine smoking habits in relation to anthropometric
parameters, systolic and diastolic blood pressure, meta-
bolic traits, and metabolic syndrome, using the SPSS
software version 17.0. The anthropometric measures we-
re adjusted for age and gender which were standardized
using age-structure of the US population, and their com-
ponents were computed by using cut-offs of all five defi-
nitions of metabolic syndrome22. We calculated Pearson’s
correlation coefficient examined the pairwise relation-
ship between the quantitative traits adjusted for age,
gender, and their interaction term, as is the Fischer Ex-
act Test (table 2 x 2). ÷2-test was applied to examine the
prevalence of smoking habits in males and females, ad-
justed for age (Table 1). Similarly, in males and females
former smokers and current smokers smoking indexes
(mild, moderate and heavy smoking) were tested (Table
2). Two-way ANOVA examined the relationship between
smoking habits and BMI and WHR in males and females,
adjusting for age (Table 3). Smoking habits of males and
females in relation to arterial HTN, by two criteria
(WHO and EGIR, and NCEP/ATP III, AHA/NHLBI and
IDF), was tested by ÷2 test (Table 4). The influence of
smoking habits and sex on metabolic traits was tested by
two-Way ANOVA (Table 5). Finally, relationships be-
tween smoking habits and MS defined by the five cri-
terias were also tested in both sex (Table 6).
Results
Table 1. presents the gender-wise prevalence of smok-
ing habits. The frequency of non-smokers was 44.7% in
females and 36.3% in males (p<0.001); of former smok-
ers was 17.5% in males and 10.1% in females (p<0.001),
and current smokers were not significantly diffferent be-
tween males (24.7%) and females (23.8%).
In Table 2. frequencies of smoking indexes in males
and females, former and current smokers are presented.
In former smokers, the frequency of mild smoking was
41.1% in females and 28.1% in males (p<0.001); of mod-
erate smoking was 27.3% in males and 18.6% in females
(p<0.001), and of heavy smoking was 9.3% in males and
3.4% in females (p<0.001). In current smoker group,
35.8% males and 26.6% females were mild smokers (p<
0.001); 31.0% males and 27.0% females were moderate
smokers (p<0.001); and males (35.9%) outnumbered fe-
males (7.7%) for heavy smoking (p<0.001).
Table 3. presents the smoking habits in relation to
BMI and WHR in males and females. The influence of
sex on BMI (p=0.001) and WHR (p<0.001), and age
(p<0.001) were all significant. In males and females re-
spectively, in nonsmokers BMI was 27.78:27.18 kg/m2; in
former smokers 28.15:27.03 kg/m2; and in current smok-
ers 26.97:25.83 kg/m2. BMI was highest in male former
smokers and female non-smokers. As regards to WHR, in
males and females respectively WHR was 0.961:0.869 in
the non-smokers; 0.973:0.851 in former smokers; 0.957:
0.854 in current smokers. The WHR was highest in male
former smokers and female non-smokers. In total, males
had higher BMI than females (27.71:26.83 kg/m2, p<
0.001), as was WHR (0.964:0.863, p<0.001).
Age-adjusted prevalence of smoking habits in relation
to arterial HTN defined by all five criteria are presented
in Table 4. By WHO and EGIR criteria, the systolic HTN
in both sex and in all the three smoker’s categories to-
gether showed a trend (p=0.088). In males and females
respectively, 20.7:15.1% nonsmokers; 17.9: 15.2% former
smokers; and 16.9:13.0% current smokers had systolic
HTN. Diastolic HTN in all the three smoker’s categories
together was more frequent in males than females (p=
0.001); respectively, 19.8:12.7% non-smokers; 22.4:10.5%
former smokers; and 11.3: 9.1% current smokers.
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TABLE 1
AGE-ADJUSTED PREVALENCE (%) OF SMOKING HABITS IN
THE POPULATION OF THE ISLAND OF HVAR (N=1,430)
Smoking habits
Sex
Males (N=602) Females (N=828)
%±SE %±SE
Non smokers 36.3±3.7 44.7±4.3
Former smokers 17.5±2.5 10.1±0.9
Current smokers 24.7±1.8 23.8±1.56
÷2=65.182, df=2, p<0.001
TABLE 2
AGE-ADJUSTED PREVALENCE (%) OF SMOKE INDEX BY














Mild (1–200) 28.1±4.5 41.1±10.4
Moderate (201–600) 27.3±5.9 18.6±6.2
Heavy (>600) 9.3±4.0 3.4±1.8
Current
smokers
Mild (1–200) 35.8±9.1 26.6±6.5
Moderate (201–600) 31.0±6.4 27.0±5.6
Heavy (>600) 35.9±7.7 7.7±1.8
former smokers: ÷2=22.697, df=2, p<0.001;
smokers: ÷2=20.200, df=2, p<0.001
By NCEP, AHA, and IDF criteria, systolic HTN was
more frequent in males than females (p<0.001); respec-
tively it was 31.4:19.8% in non-smokers, 29.9:12.7% in
former smokers, and 25.4:11.1% in current smokers.
Similarly, diastolic HTN was more frequent in males
than females (p<0.001); non-smokers 20.5:11.5%, former
smokers 24.8:11.3%, and current smokers 14.7:9.4%. Ar-
terial hypertension is statistically different among groups
according to smoking habits (p<0.001 in all hypotheses).
Table 5. presents smoking habits in relation to meta-
bolic traits in males and females. By AHA and IDF crite-
ria, serum glucose was above the normal range of ³5.6
mmol/L in all the three smoker’s categories and in both
sex, except in female current smokers. By WHO, NCEP
and EGIR criteria, serum glucose was above the normal
range of ³6.1 mmol/L in male non-smokers and former
smokers. Serum glucose in males was significantly differ-
ent than females (p<0.01) and age was the significant
factor (p<0.001). The highest serum glucose was in ma-
les and females non-smokers 6.31 and 5.91 mmol/L, res-
pectively. HbA1c levels were within the normal range of
4.3 to 6.0% in all the categories of smokers; the highest
levels were 5.83% in both sex who were non-smokers,
and age was the significant factor (p<0.001). Insulin lev-
els were also within the normal range of 2.6 to 24.9
mU/mL, and males were not significantly different from
females; the highest levels were in male former smokers
(11.60 mU/mL) and female non-smokers (11.30 mU/mL),
and age was again the significant factor (p<0.001).
Total cholesterol levels were above the normal cut-off
of <5.00 mmol/L in all the three smoker’s categories and
in both sex; females had significantly higher cholesterol
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TABLE 3
SMOKING HABITS ACCORDING TO BODY MASS INDEX AND WAIST TO HIP RATIO ACCORDING TO SEX
Sex Smoking habit
Body mass index (kg/m2) Waist to hip ratio
Count Mean Count Mean
Males
Non smokers 279 27.78 279 0.961
Former smokers 185 28.15 185 0.973
Current smokers 138 26.97 137 0.957
Total 602 27.71a 601 0.964b
Females
Non smokers 517 27.18 516 0.869
Former smokers 113 27.03 112 0.851
Current smokers 198 25.83 198 0.854
Total 828 26.83a 826 0.863b
a p=0.001, b p<0.001, p<0.001 for age as covariate
TABLE 4
AGE-ADJUSTED PREVALENCE (%) OF SMOKING HABITS ACCORDING TO ARTERIAL HYPERTENSION (N=1,430)







Non smokers 20.7±5.1 15.1±3.9
Former smokers 17.9±6.9 15.2±4.9
Current smokers 16.9±4.4 13.0±2.7
Diastolic ³90 mmHg
Non smokers 19.8±4.6 12.7±2.8
Former smokers 22.4±6.2 10.5±4.2





Non smokers 31.4±7.6 19.8±5.0
Former smokers 29.9±9.6 12.7±7.7
Current smokers 25.4±7.0 11.1±3.6
Diastolic ³85 mmHg
Non smokers 20.5±5.7 11.5±3.5
Former smokers 24.8±7.4 11.3±5.9
Current smokers 14.7±4.7 9.4±2.8
Systolic hypertension WHO: EGIR c2=3.003, df=1, p=0.088; Diastolic hypertension WHO: EGIR c2=11.300, df=1, p=0.001
Systolic hypertension NCEP, AHA/NHLBI, IDF c2=19.027, df=1, p<0.001; Diastolic NCEP, AHA/NHLBI, IDF c2=14.372, df=1,
p<0.001; According to the Fisher’s Exact Test (table 2x2)
than males (p<0.01), and age was the significant factor
(p<0.001). The highest cholesterol levels were in female
non-smokers (5.96 mmol/L) and male former smokers
(5.77 mmol/L). LDL-cholesterol was above the normal
cut-off of <3.00 mmol/L in all the three categories of
smokers and in both sex; females had higher LDL-choles-
terol than males (p<0.01), and age was the significant
factor (p<0.001). The highest LDL levels were in female
non-smokers (3.77 mmol/L) and in male former smokers
(3.66 mmol/L). The HDL-cholesterol levels were normal
in all the categories of smokers; females being signifi-
cantly different than males (p<0.01); and the highest
levels were in non-smoking females (1.55 mmol/L) as
well as males (1.33 mmol/L). Triglycerides were higher
than normal in male current smokers (1.81 mmol/L) and
male former smokers (1.76 mmol/L); males having signif-
icantly higher levels than females (p<0.01), and age be-
ing a significant factor (p<0.001).
Uric acid levels were below the normal range in all the
three smoker’s categories in both sex; males had higher
uric acid levels than females (p<0.01) and age was the
significant factor (p<0.001). The highest values were in
male (371.23 mmol/L) as well as female (272.61 mmol/L)
former smokers. Serum creatinine was in the normal
range in all the three categories in both sex, males in
general had higher values than females (p<0.01) and age
was significant (p<0.001). The highest creatinine levels
were in males (96.88 mmol/L) and females (80.03 mmol/L)
nonsmokers. Plasma fibrinogen was above the normal
range in all the categories of smokers and in both sex; be-
ing higher in females than males (p<0.01) and age being
significant (p<0.001). The highest fibrinogen levels were
in female non-smokers (4.02 g/L) and male former smok-
ers (3.63 g/L). Calcium levels were in the normal range in
all the three smoker’s categories and in both sex, and age
was the significant factor (p<0.001). The levels were
highest in male current smokers (2.40 mmol/L) and fe-
male non-smokers (2.39 mmol/L).
Table 6. presents the prevalence of smoking habits in
relation to MS defined by five criterias. According to all
these criterias, prevalence of MS was quite different be-
tween males and females and therefore gender-specific
results were presented. In males, highest prevalence of
MS was in all the three smokers’ categories using IDF
criteria; 53.8% in non-smokers, 60.5% in former smok-
ers, and 39.8% in current smokers. Lowest prevalence
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TABLE 5













Males 6.31 6.24 5.80 6.17
ad
Females 5.91 5.80 5.51 5.80
HbA1c
(4.3–6.0%)
Males 5.83 5.71 5.60 5.74
n.s. d
Females 5.83 5.72 5.59 5.76
Insulin
(2.6–24.9 mU/mL)
Males 10.69 11.60 9.73 10.75
n.s. d
Females 11.30 10.77 9.81 10.87
Total cholesterol
(<5.00 mmol/L)
Males 5.66 5.77 5.52 5.66
ad
Females 5.96 5.90 5.81 5.92
LDL-Cholesterol
(<3.00 mmol/L)
Males 3.62 3.66 3.42 3.59
ad
Females 3.77 3.75 3.74 3.76
HDL-Cholesterol
(>1.00 M, >1.2 F mmol/L)
Males 1.33 1.32 1.24 1.30
c
Females 1.55 1.53 1.46 1.52
Triglycerides
(<1.7 mmol/L)
Males 1.52 1.76 1.81 1.66
cd
Females 1.38 1.42 1.30 1.37
Uric acid
(182–403 M, 134–337 F mmol/L)
Males 357.53 371.23 350.15 360.10
ad
Females 269.72 272.61 248.77 265.11
Creatinine
(63.0–107.0 mmol/L)
Males 96.88 96.37 96.65 96.67
ad
Females 80.03 79.74 77.31 79.34
Fibrinogen
(1.6–3.5 g/L)
Males 3.57 3.63 3.57 3.59
ad
Females 4.02 3.80 3.81 3.94
Calcium
(2.14–2.53 mmol/L)
Males 2.38 2.37 2.40 2.38
n.s. d
Females 2.39 2.38 2.37 2.38
a – significant difference only by sex (p<0.01), b – significant difference only by smoking habits (p<0.01), c – significant difference by
sex and smoking habits (p<0.01), d – age is significant covariate (p<0.001)
(18.1%) was in male current smokers by EGIR criteria
and prevalence ranged between 20.3% by WHO-BMI cri-
teria in current smokers to 42.2% in former smokers us-
ing NCEP criteria. In females also using IDF criteria the
prevalence of MS was the highest; 51.4% in non-smokers,
38.2% in former smokers, and 33.0% in current smokers;
the lowest prevalence (11.6%) was in current smokers us-
ing EGIR criteria.
Discussion
The prevalence of smoking in an island population of
the Hvar in Croatia, adjusted for age according to the
standard US population, was studied. There are different
ways to define a person as smoker and former smoker.
We defined former smokers as individuals who stopped
smoking at least thirty days before the examination, and
used the number of cigarettes smoked per day multiplied
by the years of smoking to characterize smokers as cur-
rent smokers, former smokers and non-smokers. Smo-
king-index was developed to further classify current and
former smokers into mild, moderate and heavy smoking
groups. Accordingly, mild current and mild former smok-
ers were those who had an index between 1–200, moder-
ate current and moderate former smokers had an index
between 201–600, and heavy current and heavy former
smokers has an index of 601 and more12. In other studies,
frequency of smoking was based on the average number
of cigarettes smoked per day during the month9, or on
the number of cigarettes smoked per day6, or depending
on those who smoke 20 or more pack per year4; and for-
mer smokers were those who stopped smoking for more
than 3 months9.
We observed a high prevalence of smokers, with dif-
ferences in the frequency of smoking between males and
females. The number of male former smokers was higher
than female former smokers, but not much difference
was noticed between males and females who were cur-
rent smokers. The frequency of male former smokers in
this study is although higher than 15.2% reported earlier
in male industrial workers aged 40 to 59 years in Croatia,
lesser number of current smokers was observed in com-
parison to 61.7% reported in the same study12; which
could be due to differences in age, sex and profession of
the sampled population.
According to the frequency of smoking, higher num-
ber of female former smokers were mild smokers, and
higher number of males were former moderate smokers
and also former heavy smokers; this was higher than
that reported for industrial workers12. In comparison to
7.8% male industrial workers reported as mild smo-
kers12, more males than females were observed as mild
smokers in this study; however, the frequency of moder-
ate smoking was lower in both males and females when
compared to 36.2% male industrial workers as moderate
smokers12. Nevertheless, in our study the frequency of
heavy smoking was much higher in males as compared to
18.2% reported for male industrial workers12.
Majority of males and females studied were over-
weight rather than obese, and males in general had
higher BMI and WHR than females. The highest BMI
and WHR was observed in male former smokers, which
could be due to refraining from smoking; however, in fe-
males the non-smokers had the highest BMI and WHR.
Furthermore, current smokers in both sex were observed
to have the lowest BMI and WHR. It is known that
non-smoking habit can delay the disease appearance and
ageing process, thus helping in attaining longevity23,24.
However, this relationship is probably more complex as
can be seen by our findings that instead of current smok-
ers, former smokers and non-smokers weighed more.
The risk of acute coronary syndrome had been shown to
be much higher in obese smokers than non-smokers25.
The prevalence of MS is considerably high in the popula-
tion of Hvar, higher than 7.8% reported in the Japanese
population26. In our study, using BMI as an indicator of
obesity, the overall average BMI reached 27.20 kg/m2,
and WHR 0.91. By all defined criteria, except the one by
AHA/NHLBI, the prevalence of MS was much higher in
males than females when comparing former smokers
with current smokers; the highest prevalence being ob-
served by the IDF criteria.
Using all the five criteria for MS, systolic and diastolic
HTN were more prevalent in males than females in all
the three categories of smokers. However, depending on
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TABLE 6

















WHO with BMI 36.6% 35.7% 20.3% 24.7% 19.1% 12.2%
WHO with WHR 41.6% 40.5% 24.1% 25.4% 19.6% 13.6%
EGIR 38.7% 38.4% 18.1% 24.8% 18.6% 11.6%
NCEP 33.7% 42.2% 27.1% 36.8% 27.3% 21.8%
AHA/NHLBI 30.5% 38.4% 21.1% 43.4% 27.3% 27.9%
IDF 53.8% 60.5% 39.8% 51.4% 38.2% 33.0%
each criteria, differences in systolic and diastolic HTN
were noticed between males and females in each of the
three categories of smokers. In all tested hypotheses, by
two criteria and by sex, appearing of arterial hyperten-
sion is statistically different among groups according to
smoking habits. For the most part, in both sex, the
non-smokers had highest prevalence of systolic and di-
stolic HTN (except male former smokers for diastolic
HTN), and current smokers had the lowest. By some stu-
dies mean SBP in smokers was higher than non-smo-
kers25, and our results are not in agreement with their
results. On the other hand, in the Korean National
Health and Nutrition Examination Survey on 9,771 men,
no association between smoking habits and high blood
pressure had been demonstrated9.
Insulin resistance is an important element of MS.
Type 2 diabetes is a known risk factor for hyper-lipo-
proteinemia, atherosclerosis and its associated complica-
tions; males with Type 2 diabetes having 1.8 times and
females having 2.6 times higher mortality risk than
those without Type 2 diabetes 27. Smoking is also an in-
dependent risk factor for MS, insulin resistance and
Type 2 diabetes28, but its pathophysiological mechanism
is still an open area of research. In persons with Type 2
diabetes, smoking could lead to worsening of the disease
process and shortening of life-span. In this study, the av-
erage serum glucose by AHA/NHLBI and IDF were abo-
ve the normal range in all group of smokers except fe-
male current smokers; and by WHO, NCEP and EGIR
criteria these values were also above the normal range in
male non-smokers and former smokers; in general hig-
her in males than females, and highest in male and fe-
male non-smokers. HbA1c was in the normal range in all
three smoker’s group and the highest level was 5.83% in
both males and females non-smokers, with age as a sig-
nificant factor. Insulin levels were in the normal range;
with no difference between males and females; male for-
mer smokers and female non-smokers having the highest
levels; and age having a significant influence. Insulin re-
sistance was tightly linked with obesity and hyper-tri-
glyceridemia when studying 511 healthy Taiwanese29.
Likewise, obesity and insulin-resistance were the impor-
tant factors for Type 2 diabetes when comparing 305 dia-
betics with 934 non-diabetics in a study conducted in
Beijing30.
HDL-cholesterol was within the normal range in all
three group of smokers, and females were observed to
have higher levels than males; the highest levels being in
female and male non-smokers. On the other hand, tri-
glycerides were higher than normal in male current
smokers as well as male former smokers, significantly
higher in males than females, and age having a signifi-
cant influence. Smoking habit is known as an propitious
factor in aging process31,32 because of induction of inflam-
matory processes by free-oxygen radicals causing oxida-
tive damage and vascular endothelial dysfunction lead-
ing to atherosclerosis and its associated complications
such as coronary heart disease, cerebrovascular disease,
other vascular diseases, Type 2 diabetes, cancer etc. Stu-
dies have shown an association between smoking habits
and metabolic syndrome, supporting that smoking in-
creases the risk of developing insulin resistance4. In their
study, a dose dependent connection was demonstrated
between current smokers and metabolic syndrome, and
not with the former smokers. In addition, heavy smoking
increased the risk for developing metabolic syndrome,
high triglycerides and low HDL levels, while the risk for
high triglycerides and low HDL was not significant in
former smokers4.
Uric acid levels were below the normal range in cur-
rent and former smokers, in both sex, but the levels were
higher in males than females, and age was one of the fac-
tors. The levels were highest in male and female former
smokers. Elevated uric acid level is an important inde-
pendent risk factor for atherosclerosis. In addition, higher
plasma fibrinogens are known for their proinflammatory
response in atherosclerosis. In this study, fibrinogen lev-
els were above the normal range in all three group of
smokers, both males and females, females having higher
levels than males, and age being a significant factor. The
highest levels were noticed in female non-smokers and
male former smokers, which probably indicates that it is
essential to assess serum hyper-uricemia and plasma
fibrinogen as one of the determinants of MS.
Examining smoking habits of our population in rela-
tion to MS using all five criteria namely WHO, EGIR,
NCEP/ATP III, AHA/NHLBI and IDF, the highest preva-
lence was observed in both males and females using IDF
criteria. Male former smokers and female non-smokers
had the highest prevalence; in male non-smokers and fe-
male former smokers the prevalence was lower, and in
male and female current smokers lowest prevalence was
observed. In males, the lowest prevalence of MS was no-
ticed in non-smokers using AHA criteria, in former smo-
kers using WHO criteria, and in current smokers using
EGIR criteria. In females, in general lower prevalence
was observed; lowest being in current and former smok-
ers using EGIR criteria. Our findings of lower prevalence
of MS in smokers, rather than non-smokers, is in con-
trast to those reported by an earlier study in which 2,412
non-diabetic men aged 35–65 were studied and higher
frequency of MS was demonstrated in smokers than
non-smokers29.
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ODNOS NAVIKE PU[ENJA PREMA METABOLI^KIM PARAMETRIMA U OTO^NOJ
POPULACIJI ISTO^NOG JADRANA
S A @ E T A K
Istra`ena je povezanost izme|u parametara metaboli~kog sindroma (MS) i navike pu{enja u 1602 mu{karca i 828
`ena dobi 18–97 godina sa otoka Hvara. Prevalencija MS korigirana s dobi bila je vi{a u mu{karaca (18,1–31,2%) nego u
`ena (9,7–24,2%) prema svim kriterijima, osim prema AHA/NHLBI. Ukupna prevalencija MS iznosila je 12,9% prema
kriterijima SZO koriste}i indeks tjelesne mase (BMI), 13,1% prema EGIR kriterijima, 14,5% prema SZO prema krite-
rijima SZO omjera opsega struka i kukova (WHR), 18,2% prema NCEP/ATP III, 18,9% prema AHA/NHLBI i 26,7%
prema IDF kriterijima. Prevalencija navike pu{enja bila je sli~ne u~estalosti u mu{karaca (24,7%) i `ena (23,8%). U~e-
stalost lake, umjerene i te{ke navike pu{enja bila je vi{a u mu{karaca nego u `ena (35,8:26,6%, 31,0:27,0%, and 35,9:
7,7. Dob i spol bili su zna~ajno povezani s BMI and WHR, najvi{e u~estalosti u mu{karaca biv{ih pu{a~a (28,15 kg/m2
and 0.973) i u `ena nepu{a~ica (27,18 kg/m2 and 0,869). U~estalost povi{enog arterijskog krvnog tlaka (HTN) razliko-
vala se u skupinama prema navici pu{enja: u mu{karaca bila je vi{a nego u `ena prema kriterijima SZO i EGIR, visine
krvnog tlaka ³140/90 mmHg, ~ak i po korekcijama prema dobi. U mu{karaca i `ena nepu{a~a u~estalost sistoli~ke HTN
iznosila je 20,7:15.1%, u biv{ih pu{a~a 17,9:15,2%, a u pu{a~a 16,9:13,0%; dijastoli~ka HTN u nepu{a~a bila je u~esta-
losti 19,8:12,7%, u biv{ih pu{a~a 22,4:10,5%, a u pu{a~a 11,3:9,1%. Prema kriterijima NCEP, AHA i IDF visine krvnog
tlaka ³130/85 mmHg, HTN bila je vi{e u~estalosti u mu{karaca nego u `ena; sisotli~ka HTN u nepu{a~a bila je u~esta-
losti 31,4:19,8%, u biv{ih pu{a~a 29,9:12,7%, a u pu{a~a 25,4:11,1%, dok je dijastoli~ka HTN u nepu{a~a bila u~estalosti
20,5:11,5%, u biv{ih pu{a~a 24,8:11,3%, a u pu{a~a 14,7:9,4%. Prema kriterijima AHA/NHLBI i IDF povi{ene koncen-
tracije glukoze u plazmi ³5,6 mmoL/L, u mu{karaca kao i u `ena u sve tri skupine prema navici pu{enja ustanovljena je
koncentracija iznad razine normale (5,80–6,31 mmol/L u mu{karaca i 5,80–5,91 mmol/L u `ena), osim u `ena pu{a~ica
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(5,51 mmol/L). Prema kriterijima SZO, EGIR kao i NCEP/ATP III, koncentracija glukoze u krvi ³6.1 mmmol/L usta-
novljena je u samo u mu{karaca nepu{a~a (6,31 mmol/L) i mu{karaca biv{ih pu{a~a (6.24 mmol/L). Mu{karci i `ene svih
triju skupina prema navici pu{enja, imali su koncentraciju ukupnog kolesterola u serumu unutar normalnih koncen-
tracija (>1,0 mmol/L, >1,2 mmol/L): u `ena ustanovljena je vi{a koncentracija LDL-kolesterola (1,52 mmol/L) nego u
mu{karaca (1,30 mmol/L). Glede normalne koncentracije serumskih triglicerida <1,7 mmol/L, mu{karci biv{i pu{a~i
(1,76 mmol/L) i pu{a~i (1,81 mmol/L) imali su vi{u koncentraciju; u cijeloj skupini glede navike pu{enja, koncentracija
triglicerida bila je vi{a u mu{karaca nego u `ena: 1,66:1,37 mmol/L. Prevalencija MS prema razli~itim kriterijima,
razlikovala se u mu{karaca i `ena. I mu{karci i `ena imali su najvi{u u~estalost MS prema IDF kriterijima; mu{karci
biv{i pu{a~i 60,5%, `ene nepu{a~ice 51,4%, mu{karci nepu{a~i 53,8%, `ene biv{e pu{a~ice 38,2%, a najni`a u~estalost
ustanovljena je u mu{karaca pu{a~a i `ena pu{a~ica: 39,8 and 33,0%. U mu{karaca najni`a u~estalost MS sutanovljena
je u nepu{a~a prema AHA kriterijima: 30,5%, u biv{ih pu{a~a prema SZO kriterijima: 35,7%, i u pu{a~a prema EGIR
kriterijima: 18,1%. U `ena u sve tri skupine prema navici pu{enja, najni`a je u~estalost MS ustanovljena prema EGIR i
SZO kriterijima. Ni`a u~estalost MS ustanovljena je u pu{a~a, u odnosu prema nepu{a~ima i biv{im pu{a~ima.
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